HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,093,648 | -66.8% | 718,244 | -70.5% | 0.03% | -66.7% |
Q2 2023 | $250,235,080 | +734.9% | 2,433,010 | +786.0% | 0.08% | +663.6% |
Q1 2023 | $29,971,808 | -47.3% | 274,618 | -45.1% | 0.01% | -47.6% |
Q4 2022 | $56,892,716 | +59.8% | 499,936 | -13.1% | 0.02% | +31.2% |
Q3 2022 | $35,595,000 | -5.7% | 575,137 | +21.6% | 0.02% | +6.7% |
Q2 2022 | $37,729,000 | -30.5% | 473,034 | -8.3% | 0.02% | -16.7% |
Q1 2022 | $54,253,000 | -20.8% | 515,652 | -18.9% | 0.02% | -10.0% |
Q4 2021 | $68,487,000 | +10.1% | 635,548 | +11.9% | 0.02% | 0.0% |
Q3 2021 | $62,216,000 | +79.1% | 567,969 | +53.1% | 0.02% | +81.8% |
Q2 2021 | $34,729,000 | -12.6% | 370,870 | -14.1% | 0.01% | -15.4% |
Q1 2021 | $39,735,000 | -33.4% | 431,722 | -47.1% | 0.01% | -35.0% |
Q4 2020 | $59,673,000 | +179.1% | 815,757 | +196.3% | 0.02% | +150.0% |
Q3 2020 | $21,384,000 | +187.0% | 275,292 | +105.3% | 0.01% | +166.7% |
Q2 2020 | $7,452,000 | -16.5% | 134,084 | -55.5% | 0.00% | -25.0% |
Q1 2020 | $8,922,000 | +15.4% | 301,228 | +41.1% | 0.00% | +33.3% |
Q4 2019 | $7,729,000 | +39.5% | 213,502 | +4.9% | 0.00% | +50.0% |
Q3 2019 | $5,542,000 | +1.0% | 203,522 | -10.8% | 0.00% | 0.0% |
Q2 2019 | $5,486,000 | – | 228,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |